Synthesis of Bispecific Conjugates by ADP‐Ribosyl Cyclases
Advanced Science · 2026-03 · 13 (13)
DOI: 10.1002/advs.202518329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 21.12.2025. Verfasst von Sunny H Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern Califor…. Hauptthemen laut MEDLINE: Antibodies, Bispecific, ADP-ribosyl Cyclase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Armed with two distinct targeting moieties, artificially created bispecific agents can uniquely modulate various processes and events implicated in human health and diseases. Despite recent approvals of multiple bispecific therapeutics, generation of homogeneous dual‐targeting constructs with desired pharmacological properties remains technically challenging. Here, we report a strategy for synthesis of bispecific agents by utilizing CD38, a member of the ADP‐ribosyl cyclase family, and its covalent inhibitor. A model ADP‐ribosyl cyclase‐enabled bispecific conjugate (ARC‐BsC) against human T‐cell CD3 and prostate‐specific membrane antigen (PSMA) is generated through site‐specific conjugation of an anti‐CD3 antibody‐CD38 fusion with the CD38 covalent inhibitor derivatized by a PSMA small‐molecule ligand. The resulting ARC‐BsC can redirect and activate cytotoxic T cells toward killing PSMA‐expressing tumor cells, eliciting highly potent and selective anti‐cancer immunity in vitro and in vivo. This proof‐of‐concept work demonstrates ARC‐BsC as a potentially general approach for the development of bispecific therapeutics with diverse applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USA.
- Department of Chemistry, University of California, Irvine, CA, USA.
- Department of Chemistry, Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, USA.
- Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
- Research Center for Liver Diseases, University of Southern California, Los Angeles, CA, USA.
ORCID-Profile: Sunny H Kim, Arshad J Ansari, Yong Zhang
Förderung
- NIBIB NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- National Cancer Institute
- National Institute of Biomedical Imaging and Bioengineering
- National Institute of General Medical Sciences
Zitieren
APA
Kim, S. H., Ansari, A. J., Zhang, L., Kao, G., Hoang, T. O., Zhang, Z., Singireddi, S., Katz, B. B., & Zhang, Y. (2026). Synthesis of Bispecific Conjugates by ADP‐Ribosyl Cyclases. Advanced Science, 13(13). https://doi.org/10.1002/advs.202518329
Vancouver
Kim SH, Ansari AJ, Zhang L, Kao G, Hoang TO, Zhang Z, et al. Synthesis of Bispecific Conjugates by ADP‐Ribosyl Cyclases. Advanced Science. 2026;13(13). doi:10.1002/advs.202518329
BibTeX
@article{Kim2026,
author = {Kim, Sunny H and Ansari, Arshad J and Zhang, Lei and Kao, Guoyun and Hoang, Thuc Oanh and Zhang, Zeyu and Singireddi, Srinivasarao and Katz, Benjamin B and Zhang, Yong},
title = {Synthesis of Bispecific Conjugates by ADP‐Ribosyl Cyclases},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {13},
doi = {10.1002/advs.202518329}
}
EUVIMED